Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor

被引:79
作者
Menges, C. W. [1 ,2 ,3 ]
McCance, D. J. [1 ,4 ,5 ,6 ]
机构
[1] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland
[2] Univ Rochester, Sch Med, Dept Biochem, Rochester, NY USA
[3] Univ Rochester, Sch Med, Dept Biophys, Rochester, NY USA
[4] Univ Rochester, Sch Med, Dept Microbiol, Rochester, NY USA
[5] Univ Rochester, Sch Med, Dept Immunol, Rochester, NY USA
[6] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA
关键词
Raf-MEK1; Ras; PI3; AKT; kinase; EphA(2) receptor;
D O I
10.1038/sj.onc.1210957
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Raf-mitogen-activated protein kinase (MAPK) and phosphatidylinositide 3-kinase (PI3K)-AKT pathways are two downstream effectors of the small GTPase Ras. Although both pathways are positively regulated by Ras, the Raf-MAPK and PI3K-AKT pathways have been shown to control opposing functions within the cell, suggesting a need for cross-talk regulation. The PI3K -AKT pathway can inhibit the Raf-MAPK pathway directly during processes such as muscle differentiation. Here we describe the ability of the Raf-MAPK pathway to negatively regulate the PI3K-AKT pathway during cellular arrest. Constitutive activation of Raf or methyl ethyl ketone 1 (MEK1) leads to inhibition of AKT and cellular arrest. Furthermore, we show that activation of Raf-MEK1 signaling causes negative feedback inhibition of Ras through the ephrin receptor EphA(2). EphA(2)-mediated negative feedback inhibition is required for Raf-induced AKT inhibition and cell cycle arrest, therefore establishing the inhibition of the Ras-PI3K-AKT pathway as a necessary event for the Raf-MEK1-regulated cellular arrest.
引用
收藏
页码:2934 / 2940
页数:7
相关论文
共 28 条
[1]   Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo [J].
Brantley, DM ;
Cheng, N ;
Thompson, EJ ;
Lin, Q ;
Brekken, RA ;
Thorpe, PE ;
Muraoka, RS ;
Cerretti, DP ;
Pozzi, A ;
Jackson, D ;
Lin, C ;
Chen, J .
ONCOGENE, 2002, 21 (46) :7011-7026
[2]   PKB binding proteins: Getting in on the akt [J].
Brazil, DP ;
Park, J ;
Hemmings, BA .
CELL, 2002, 111 (03) :293-303
[3]  
Cheng N, 2002, MOL CANCER RES, V1, P2
[4]   Mechanisms of regulating the Raf kinase family [J].
Chong, H ;
Vikis, HG ;
Guan, KL .
CELLULAR SIGNALLING, 2003, 15 (05) :463-469
[5]   Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor [J].
Cichowski, K ;
Santiago, S ;
Jardim, M ;
Johnson, BW ;
Jacks, T .
GENES & DEVELOPMENT, 2003, 17 (04) :449-454
[6]   A negative feedback signaling network underlies oncogene-induced senescence [J].
Courtois-Cox, Stephanie ;
Williams, Sybil M. Genther ;
Reczek, Elizabeth E. ;
Johnson, Bryan W. ;
McGillicuddy, Lauren T. ;
Johannessen, Cory M. ;
Hollstein, Pablo E. ;
MacCollin, Mia ;
Cichowski, Karen .
CANCER CELL, 2006, 10 (06) :459-472
[7]   Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions [J].
Hobbs, RM ;
Silva-Vargas, V ;
Groves, R ;
Watt, FM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (03) :503-515
[8]  
Holt KH, 1996, MOL CELL BIOL, V16, P577
[9]   Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer [J].
Kinch, MS ;
Carles-Kinch, K .
CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (01) :59-68
[10]   Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells [J].
Laprise, P ;
Langlois, MJ ;
Boucher, MJ ;
Jobin, C ;
Rivard, N .
JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 199 (01) :32-39